Semaglutide | South Africa Drug Approvals | Medicines Control Council | PharmaCompass.com

Please Wait

Applying Filters...

Semaglutide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

62 API Suppliers, 33 USDMF, 3 KDMF, 56 NDC API, 34 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

57 Drugs in Development

57 Drugs in Development

INTERMEDIATES

5 Intermediates Suppliers

5 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

70 FDF Dossiers, 14 FDA Orange Book, 12 Europe, 11 Canada, 4 Australia, 2 South Africa, 27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;SUBCUTANEOUS - 2MG/3ML (0.68MG/ML), SOLUTION;SUBCUTANEOUS - 2MG/1.5ML (1.34MG/ML), SOLUTION;SUBCUTANEOUS - 4MG/3ML (1.34MG/ML), SOLUTION;SUBCUTANEOUS - 8MG/3ML (2.68MG/ML)

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 BASF, 1 Finar, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

3 Topical, 2 Film Formers & Plasticizers, 2 Solubilizers, 1 Emulsifying Agents, 1 Thickeners and Stabilizers, 1 Parenteral

DIGITAL CONTENT

10 DATA COMPILATION #PharmaFlow, 9 STOCK RECAP #PipelineProspector, 429 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 12 Finished Drug Prices, 13 Annual Reports

MARKET PLACE

47 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

147 US Patents, 17 US Exclusivities

$ Xls

Filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2Novo Nordisk (Pty) Ltd

filter Active Ingredients Reset all filters

filter Dosage Form Reset all filters

filter Brand Name Reset all filters

List of Suppliers

Product Main Page

01

Novo Nordisk (Pty) Ltd

2024 ACI Convention

Not Confirmed

02

Novo Nordisk (Pty) Ltd

2024 ACI Convention

Not Confirmed

Contact us
to update this info